To analyze the prevalence of homologous recombination deficiency (HRD) in patients with pancreatic ductal adenocarcinoma (PDAC).

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis

Casolino, Raffaella;Paiella, Salvatore;Corbo, Vincenzo;Milella, Michele;Scarpa, Aldo;Pea, Antonio;Malleo, Giuseppe;Salvia, Roberto;Bassi, Claudio;
2021

Abstract

To analyze the prevalence of homologous recombination deficiency (HRD) in patients with pancreatic ductal adenocarcinoma (PDAC).
JOINT-CONSENSUS-RECOMMENDATION, FOR-MOLECULAR-PATHOLOGY, DETECT PUBLICATION BIAS, DNA-DAMAGE RESPONSE, BREAST-CANCER, DUCTAL ADENOCARCINOMA, MUTATIONAL SIGNATURES,GERMLINE MUTATIONS, SEQUENCE VARIANTS, MEDICAL GENETICS
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1045647
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 26
social impact